Skip to main content
. 2023 Feb 15;15(4):1233. doi: 10.3390/cancers15041233

Figure 1.

Figure 1

PazoQoL study design. STS, soft tissue sarcoma; V1–4, visit 1–4; HB, home based patient reported outcome measures; PFS, progression free survival; OS, overall survival; ORR, objective remission rate; CBR, clinical benefit rate; QLQ C30, EORTC QoL questionnaire; BPI-SF, brief pain inventory; CTSQ, Cancer therapy satisfaction questionnaire; FAACT, functional assessment of anorexia/cachexia therapy; MDASI, M.D. Anderson symptom inventory; MFI, multidimensional fatigue inventory.